ArticleFrontiers in oncology2024

Evaluating ChatGPT-4o as a decision support tool in multidisciplinary sarcoma tumor boards: heterogeneous performance across various specialties.

Tekoshin Ammo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.